VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $15,595,000 | -21.3% | 676,874 | 0.0% | 0.07% | 0.0% |
| Q4 2019 | $19,819,000 | +9.6% | 676,874 | 0.0% | 0.07% | -5.7% |
| Q3 2019 | $18,079,000 | +4.5% | 676,874 | 0.0% | 0.07% | +6.1% |
| Q2 2019 | $17,301,000 | +14.0% | 676,874 | 0.0% | 0.07% | +10.0% |
| Q1 2019 | $15,176,000 | +6.3% | 676,874 | 0.0% | 0.06% | -3.2% |
| Q4 2018 | $14,275,000 | +162.0% | 676,874 | +130.1% | 0.06% | +210.0% |
| Q3 2018 | $5,449,000 | -17.0% | 294,210 | 0.0% | 0.02% | -39.4% |
| Q2 2018 | $6,564,000 | +1.5% | 294,210 | 0.0% | 0.03% | -5.7% |
| Q1 2018 | $6,467,000 | -5.4% | 294,210 | 0.0% | 0.04% | +25.0% |
| Q4 2017 | $6,837,000 | +1.2% | 294,210 | 0.0% | 0.03% | -6.7% |
| Q3 2017 | $6,755,000 | +4.0% | 294,210 | 0.0% | 0.03% | -3.2% |
| Q2 2017 | $6,496,000 | -69.3% | 294,210 | -68.3% | 0.03% | -70.2% |
| Q1 2017 | $21,156,000 | +9.0% | 927,472 | 0.0% | 0.10% | +3.0% |
| Q4 2016 | $19,403,000 | -20.8% | 927,472 | 0.0% | 0.10% | -15.1% |
| Q3 2016 | $24,513,000 | -4.6% | 927,472 | 0.0% | 0.12% | -10.5% |
| Q2 2016 | $25,691,000 | – | 927,472 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |